|
N-Nitrosamine Formation in Pharmaceutical Drug Products: Development and Validation of a Biased, Conservative, Predictive Model-Pub
|
|
4
|
451
|
November 24, 2025
|
|
In Vitro Metabolism Study of NDSRIs
|
|
3
|
275
|
November 20, 2025
|
|
Grenzwert für N-nitroso oxymetazoline
|
|
4
|
124
|
November 19, 2025
|
|
🇪🇬 Egypt (EDA) Public Consultation regarding the Guidelines for Nitrosamine Impurities
|
|
0
|
109
|
November 19, 2025
|
|
Studies addressing potential bioactivation and genotoxicity liabilities of the N-nitroso derivative of the antidepressant paroxetine-Pub
|
|
0
|
110
|
November 18, 2025
|
|
Nitrosamine Contamination in Pharmaceuticals: A Retrospective Regulatory Analysis of USFDA Recalls and Risk Mitigation Strategies (2018–2025)-Pub
|
|
0
|
223
|
November 18, 2025
|
|
N-Nitroso-Desmethyl-tetracycline MOA development
|
|
1
|
158
|
November 18, 2025
|
|
N nitroso urapidil
|
|
0
|
83
|
November 18, 2025
|
|
EMA - nitrosamines Leading Member State (LMS)
|
|
2
|
313
|
November 13, 2025
|
|
N-Nitroso-API calculation limit
|
|
9
|
795
|
November 13, 2025
|
|
FDA is serious about risk assessments!
|
|
3
|
623
|
November 11, 2025
|
|
Nitrosamine Control: From Risk Assessment to Analytical Testing with Emphasis on Sample Preparation and Phase-Appropriate Method Validation-Pub
|
|
0
|
324
|
November 8, 2025
|
|
N-nitrosamine occurrence in disinfected drinking water
|
|
0
|
248
|
November 5, 2025
|
|
FDA recalls blood pressure medicine over cancerous chemical
|
|
2
|
503
|
November 5, 2025
|
|
Nitrosamine Bootcamp in Indonesia & Korea
|
|
0
|
234
|
November 4, 2025
|
|
:australia: TGA - Latest Update to Nitrosamine Limits
|
|
10
|
2371
|
November 3, 2025
|
|
Construction of a modified Arrhenius equation for predicting drug nitrosation in solid dosage form -Pub
|
|
2
|
701
|
October 30, 2025
|
|
Nitrocellulose-Based Packaging Inks and Nitrosamine Risk
|
|
0
|
318
|
October 28, 2025
|
|
Determination of N-nitroso desmethyl Tetracycline
|
|
17
|
1078
|
October 27, 2025
|
|
🖥 Nitrosamines risk from Water for Pharmaceutical Purpose according to USP
|
|
2
|
920
|
October 24, 2025
|
|
IPEC Excipient new questionnaire, October 2025
|
|
2
|
239
|
October 23, 2025
|
|
N-Nitroso Sertraline
|
|
9
|
939
|
October 23, 2025
|
|
Updated: IPEC Questionnaire for Excipient Nitrosamines Risk Evaluation
|
|
2
|
574
|
October 23, 2025
|
|
Computational mechanistic study on N-nitrosation reaction of secondary amines-New pub
|
|
2
|
497
|
October 21, 2025
|
|
Guidelines for Antibiotic group drug substances for the limit of Nitrosamine impurities . (Eg. Azithromycin, Erythromycin )
|
|
5
|
2004
|
October 20, 2025
|
|
Carbazole reaction with nitrites
|
|
6
|
325
|
October 17, 2025
|
|
N-Nitrosamine Quantitation in Pharmaceuticals by Tandem Mass Spectrometry
|
|
1
|
302
|
October 16, 2025
|
|
Peptide Synthesis - Does anyone have experience with potential Nitrosamine impurities coming from solid phase synthesis?
|
|
1
|
198
|
October 16, 2025
|
|
N-Nitroso mirabegron
|
|
7
|
2733
|
October 15, 2025
|
|
Understanding nitrosamine risk in listed medicines
|
|
2
|
367
|
October 14, 2025
|